Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 18, 2024 10:05 ET | Source: TigaTx, Inc.

TigaTx Announces up to $35.5M in Funding from ARPA-H and NIH Awards to Advance First-in-Class Engineered IgA Monoclonal Antibody for Cancer and Infectious Diseases

TigaTx announces up to $35.5M in funding from ARPA-H and NIH awards to advance first-in-class engineered IgA monoclonal antibody for cancer.